Neurovascular Catheter Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Over-The-Wire Microcatheters, Flow-Directed Microcatheters, and 1 more

Neurovascular Catheter Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Over-The-Wire Microcatheters, Flow-Directed Microcatheters, and 1 more

The global neurovascular catheter market reached a value of about $530 million in 2022 and is expected to grow at a CAGR of 2.7% to reach $640 million during the forecast period. The market includes various types of catheters such as over-the-wire microcatheters, flow-directed microcatheters, and neurovascular guiding catheters

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL NEUROVASCULAR CATHETER MARKET INSIGHTS

One of the main market drivers is the increasing volume of procedures being performed using endovascular techniques, leading to a rise in the number of catheters required. However, the use of neurovascular catheters may face resistance from older-generation neurosurgeons who prefer surgical techniques and are not yet comfortable with endovascular procedures, potentially limiting market growth.

GLOBAL NEUROVASCULAR CATHETER MARKET SHARE INSIGHTS

Within the global market for neurovascular catheter, there are three key market players – Penumbra, Stryker, and Medtronic.
Penumbra held the top position in the global neurovascular catheter market in 2022, with a range of products including the BenchmarkTM071 distal delivery catheter, the PX SLIM™ microcatheter, the NeuronTM system, and a series of Penumbra Select™ catheters.

MARKET SEGMENTATION SUMMARY

Global Over-the-Wire Microcatheter Market
Global Flow-Directed Microcatheter Market
Neurovascular Guiding Catheter Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage– iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing– When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.